Biotech co PepGen's shares leap in Nasdaq debut

** Shares of PepGen Inc  PEPG.O  opened up 30% in its stock
market debut on Friday
    ** Shares were last up 11.08% at $13.33
    ** The clinical stage biotechnology co's shares opened at
$15.6; it had sold shares at $12 in its initial public offering
on Thursday 
    ** PEPG sold 9 mln shares in an upsized IPO, raising about
$108 mln  urn:newsml:reuters.com:*:nGNX6vWwdn
    ** Co had earlier expected to sell 7.2 mln shares priced
between $13 and $15 per share, according to a recent regulatory
filing https://www.sec.gov/Archives/edgar/data/0001835597/000119312522140581/d235586ds1a.htm
 
    ** Co is involved in the development of therapies for the
treatment of severe neuromuscular and neurological diseases
    ** BofA Securities, SVB Securities, and Stifel were the
joint book-running managers for the offering 

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))

Recent news on PepGen

See all news